Bayforest Capital’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Bayforest Capital's VCYT Position: Q2 2026 in Review
Bayforest Capital reduced its Veracyte (VCYT) stake by 39% in Q2 2026, selling an estimated $19.8K and leaving 725 shares worth $42.6K. The position accounts for 0.04% of the portfolio, ranked #652.
Bayforest Capital first reported a position in VCYT in Q3 2025 and has held it in 4 quarters since. The position peaked at $516K in Q3 2025. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Bayforest Capital held 725 shares of Veracyte worth $42.6K as of Q2 2026.
- Bayforest Capital sold 471 Veracyte shares in Q2 2026, an estimated $19.8K.
- Veracyte made up 0.04% of Bayforest Capital's portfolio in Q2 2026, its #652 holding.
- Bayforest Capital first reported a position in Veracyte in Q3 2025 and has held it in 4 quarters since.
- Bayforest Capital's Veracyte position peaked at $516K in Q3 2025.
- 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.